Prolonged survival in secondary glioblastoma following local injection of targeted alpha therapy with 213Bi-substance P analogue

被引：0
|
作者：
Leszek Krolicki
Frank Bruchertseifer
Jolanta Kunikowska
Henryk Koziara
Bartosz Królicki
Maciej Jakuciński
Dariusz Pawlak
Christos Apostolidis
Saed Mirzadeh
Rafał Rola
Adrian Merlo
Alfred Morgenstern
机构：
[1] Medical University of Warsaw,Department of Nuclear Medicine
[2] European Commission,Department of Neurosurgery
[3] Joint Research Centre,Department of Nuclear Medicine
[4] Directorate for Nuclear Safety and Security,Radioisotope Centre POLATOM
[5] Institute of Psychiatry and Neurology,Nuclear and Radiochemistry Group, Nuclear Security and Isotope Technology Division
[6] Brodnowski Hospital,Department of Neurology
[7] National Centre for Nuclear Research,Neurosurgery
[8] Oak Ridge National Laboratory,undefined
[9] Military Institute of Aviation Medicine,undefined
[10] Bern and University of Basel,undefined
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2018年 / 45卷
关键词：
Glioblastoma; GBM; Bi-DOTA-SP; Ga-DOTA-SP; Targeted alpha therapy; Substance P;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1636 / 1644
页数：8
相关论文
共 23 条
  • [1] Prolonged survival in secondary glioblastoma following local injection of targeted alpha therapy with 213Bi-substance P analogue
    Krolicki, Leszek
    Bruchertseifer, Frank
    Kunikowska, Jolanta
    Koziara, Henryk
    Krolicki, Bartosz
    Jakucinski, Maciej
    Pawlak, Dariusz
    Apostolidis, Christos
    Mirzadeh, Saed
    Rola, Rafal
    Merlo, Adrian
    Morgenstern, Alfred
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 (09) : 1636 - 1644
  • [2] Targeted Alpha Therapy of Glioblastoma Multiforme: Initial Clinical Experience with 213Bi-Substance P
    Morgenstern, A.
    Krolicki, L.
    Kunikowska, J.
    Koziara, H.
    Krolicki, B.
    Jakucinski, M.
    Mikolajczak, R.
    Pawlak, D.
    Apostolidis, C.
    Bruchertseifer, F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S244 - S244
  • [3] Targeted alpha therapy of glioblastoma multiforme: First clinical experience with 213Bi-substance P
    Morgenstern, Alfred
    Krolicki, Leszek
    Kunikowska, Jolanta
    Koziara, Henryk
    Krolicki, Bartosz
    Jakucinski, Maciej
    Apostolidis, Christos
    Bruchertseifer, Frank
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [4] Secondary glioblastoma multiforme - local alpha emiters targeted therapy with 213Bi-DOTA-substance P
    Krolicki, L.
    Morgenstern, A.
    Kunikowska, J.
    Koziara, H.
    Krolicki, B.
    Jakucinski, M.
    Pawlak, D.
    Apostolidis, C.
    Bruchertseifer, F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S158 - S158
  • [5] Alphaknife for glioma tumors: two years experiences with targeted alpha therapy of 213Bi-substance P
    Krolicki, L.
    Morgenstern, A.
    Kunikowska, J.
    Koziara, H.
    Krolicki, B.
    Jakucinski, M.
    Apostolidis, C.
    Bruchertseifer, F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S291 - S292
  • [6] Recurrent glioblastoma multiforme - local alpha emiters targeted therapy with 213Bi-DOTA-substance P
    Krolicki, L.
    Morgenstern, A.
    Kunikowska, J.
    Koziara, H.
    Krolicki, B.
    Jakucinski, M.
    Pawlak, D.
    Apostolidis, C.
    Bruchertseifer, F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S84 - S85
  • [7] Recurrent glioblastoma multiforme - targeted alpha therapy with 213Bi-DOTA-Substance P
    Krolicki, L.
    Krolicki, B.
    Morgenstern, A.
    Kunikowska, J.
    Koziara, H.
    Jakucinski, M.
    Apostolidis, C.
    Bruchertseifer, F.
    RADIOTHERAPY AND ONCOLOGY, 2016, 118 : S16 - S16
  • [8] Safety and efficacy of targeted alpha therapy with 213Bi-DOTA-substance P in recurrent glioblastoma
    Leszek Królicki
    Frank Bruchertseifer
    Jolanta Kunikowska
    Henryk Koziara
    Bartosz Królicki
    Maciej Jakuciński
    Dariusz Pawlak
    Christos Apostolidis
    Saed Mirzadeh
    Rafał Rola
    Adrian Merlo
    Alfred Morgenstern
    European Journal of Nuclear Medicine and Molecular Imaging, 2019, 46 : 614 - 622
  • [9] Safety and efficacy of targeted alpha therapy with 213Bi-DOTA-substance P in recurrent glioblastoma
    Krolicki, Leszek
    Bruchertseifer, Frank
    Kunikowska, Jolanta
    Koziara, Henryk
    Krolicki, Bartosz
    Jakucinski, Maciej
    Pawlak, Dariusz
    Apostolidis, Christos
    Mirzadeh, Saed
    Rola, Rafal
    Merlo, Adrian
    Morgenstern, Alfred
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (03) : 614 - 622
  • [10] 225AC- and 213Bi-Substance P Analogues for Glioma Therapy
    Krolicki, Leszek
    Kunikowska, Jolanta
    Bruchertseifer, Frank
    Koziara, Henryk
    Krolicki, Bartosz
    Jakucinski, Maciej
    Pawlak, Dariusz
    Rola, Rafal
    Morgenstern, Alfred
    Rosiak, Elzbieta
    Merlo, Adrian
    SEMINARS IN NUCLEAR MEDICINE, 2020, 50 (02) : 141 - 151
123